The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from Mounjaro maker Eli Lilly.Read More
You might also be interested in reading Is The Dogecoin Rally A Dead Cat Bounce? Analysts Weigh In.